课题基金 / 基金详情

内皮细胞中PDI的巯基硫化修饰在主动脉夹层中的作用及机制研究

批准号:
82100414
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
赵爽
依托单位:
学科分类:
血管发生及血管结构与功能异常
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
赵爽

项目摘要

结项摘要

赵爽的其他基金

相似基金

相关文献

中文摘要
主动脉夹层(AD)是一类十分凶险的疾病,血管内膜损伤作为其发生的始动因素,在AD中至关重要,H2S介导的巯基硫化修饰能够影响蛋白功能,参与多种疾病的调控,但其在AD中的作用尚不清楚。二硫键异构酶(PDI)与内质网功能密切相关,其是否参与AD尚无报道。预实验显示,AD患者和AD模型小鼠血浆H2S水平下降;质谱结合生物信息学分析提示内皮细胞中PDI是潜在的巯基硫化修饰靶点;AD小鼠血管组织以及AngII刺激的内皮细胞中PDI巯基硫化修饰水平下降;给予H2S供体能增加PDI巯基硫化修饰,改善AngII导致的内皮细胞内质网应激;PDI修饰位点突变后H2S促进其蛋白构象变化作用消失。本项目将从动物、细胞和分子水平,采用蛋白质组学和分子生物学等手段,验证假说:PDI巯基硫化修饰下降会影响其活性,导致内质网应激,介导内皮损伤和AD发生。本项目可揭示内皮损伤和AD发生新机制,为AD防治提供新靶点和策略。
英文摘要
Aortic dissection (AD) is a kind of extremely dangerous disease. Vascular intimal injury, as the initiating factor, plays an important role in AD. Protein S-sulfhydration mediated by hydrogen sulfide (H2S) could regulate numerous protein function and activity and involve in many diseases. However, the precise role of S-sulfhydration in AD remains unclear. Protein disulfide isomerase (PDI) is essential for endoplasmic reticulum function, but its role in AD remains unknown. Our preliminary results showed that the plasma H2S level was decreased in AD patients and mice. Mass spectrum based bioinformatics analysis suggested PDI as a potential S-sulfhydrated target in endothelium. The S-sulfhydration of PDI was significantly decreased in AD mice and AngII-stimulated endothelial cells. H2S donor (GYY4137) treatment could reverse the decreased S-sulfhydration of PDI and improve ER stress induced by AngII. Mutation of S-sulfhydration sites abolished the effect of H2S on the PDI conformational transformation. In the present proposal, we hypothesize that S-sulfhydration of PDI could alter its activity to regulate ER stress, further mediating the endothelial dysfunction and AD. This project will test the hypothesis in combination with proteomics and molecular biology methods both in vivo and in vitro. The study may reveal the new mechanism of AD and vascular intimal injury, which will provide new targets and strategies for the prevention and treatment of AD.
主动脉瘤/夹层(AAD)是一类十分凶险的疾病,血管内皮细胞损伤是其发生的始动因素。蛋白质巯基硫化(SSH)修饰是一种新发现的翻译后修饰类型,其在 AAD 中的作用尚未明确,本项目旨在探讨内皮细胞中蛋白质的巯基硫化修饰参与AAD的具体机制。我们发现患者血浆硫化氢(H2S)水平与AAD 风险呈负相关。AAD小鼠内皮细胞和AAD患者主动脉中CSE表达下降。内皮细胞中蛋白质二硫异构酶(PDI)是潜在的发生巯基硫化修饰靶蛋白,并且其修饰水平在病理条件下明显下降。PDI的第343和400位点的半胱氨酸发生巯基硫化修饰能增加其活性,减轻内质网应激。在内皮细胞特异性过表达CSE的小鼠中,PDI-SSH修饰水平增加,并缓解AAD病变。机制研究证明,内皮细胞中ZEB2能够招募HDAC1-NuRD复合物,抑制CSE的基因转录,进而抑制PDI-SSH修饰。内皮细胞特异性敲除HDAC1能够增加PDI-SSH修饰,从而改善AAD。并且使用H2S供体GYY4137或药物恩替诺特抑制 HDAC1活性后能够增加PDI-SSH修饰水平,进而改善小鼠AAD病变。本项目揭示了H2S 介导的内皮细胞中PDI-SSH修饰在AAD中的关键调控作用,有望为AAD的临床防治提供潜在的新靶点和新策略。
心肌细胞中SLC44A2在心脏重构中的作用和机制研究
  • 批准号:
    82370262
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    赵爽
  • 依托单位:
国内基金
海外基金